{"nct_id":"NCT01494610","title":"Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.","status":"COMPLETED","status_verified_date":"2019-02","start_date":"2010-10-25","start_date_type":"ACTUAL","primary_completion_date":"2011-06-08","primary_completion_date_type":"ACTUAL","completion_date":"2011-06-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}